VAERS reports by lot

GSK Varicella/Shingles lot 92M54: VAERS reports

27 VAERS reports list lot 92M54 as a GSK Varicella/Shingles vaccine, received between 2019-04-18 and 2020-02-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
4%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2925%
Injection-site / Local reaction2421%
Neurological1513%
Musculoskeletal1412%
Dermatological (non-injection-site)1210%
Cardiac / Cardiovascular65%
Allergic / Anaphylactic54%
Respiratory54%
Psychiatric / Neuropsychiatric33%
Gastrointestinal22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
Maryland3
Virginia3
Indiana2
Ohio2
Washington2
Georgia1
New York1
Wisconsin1
Michigan1
Connecticut1
Pennsylvania1

Reports by month received

2019-042
2019-059
2019-064
2019-077
2019-082
2019-091
2019-101
2020-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.